Anderson Kathryn Tinsley, Bartz-Kurycki Marisa A, Martin Robert, Imseis Essam, Austin Mary T, Speer Allison L, Lally Kevin P, Tsao Kuojen
Department of Pediatric Surgery, Center for Surgical Trials and Evidence-based Practice, McGovern Medical School, The University of Texas Health Science Center, Houston and Children's Memorial Hermann Hospital, Houston, Texas.
Department of Pediatric Surgery, Center for Surgical Trials and Evidence-based Practice, McGovern Medical School, The University of Texas Health Science Center, Houston and Children's Memorial Hermann Hospital, Houston, Texas.
J Surg Res. 2018 Nov;231:346-351. doi: 10.1016/j.jss.2018.05.081. Epub 2018 Jun 29.
Parenteral nutrition for intestinal failure (IF) often requires a tunneled central venous catheter (CVC). The purpose of this study was to characterize complications after CVC placement and contributors to line loss in pediatric IF patients.
An institutional review board-approved retrospective review of pediatric (<18 y) IF patients who had a silicone tunneled CVC newly inserted or exchanged from 2012 to 2016 in an IF center was conducted. Patient demographics, procedure service (surgery versus interventional radiology), procedure type (new versus exchange), vessel, and complications related to CVCs were evaluated. Complications included dislodgement, infection, break, occlusion/malfunction, and others. An ethanol-lock protocol for silicone CVCs in IF patients was instituted in January 2012.
Twenty-nine IF patients with tunneled CVCs were identified with 182 lines and 18,534 line d. Median age at line insertion was 17.1 mo (interquartile range [IQR] 7.6-31.5) with a median of five catheters (IQR 2-8) per patient. There were 19.2 complications per 1000 line d. Occlusions/malfunctions were the most common complication (6.0/1000 line d) followed by breaks (5.6/1000 line d). Median life of catheters was 51.5 d (IQR 21-129). On regression, adjusting for age, insertion service, and procedure type, shorter line life was associated with younger age (P = 0.04) and placement by interventional radiology (P < 0.01). Dislodgement was associated with newly placed lines relative risk 6.5 (95% CI 2.2-28.8).
CVCs in pediatric IF patients have frequent complications and short line lifetimes. Dislodgement of CVC was an unexpectedly common complication with loss of access in newly placed lines. There may be modifiable processes to mitigate CVC complications.
肠道衰竭(IF)患者的肠外营养通常需要置入带隧道的中心静脉导管(CVC)。本研究旨在描述小儿IF患者CVC置入后的并发症及导致导管失用的因素。
对2012年至2016年在一家IF中心新插入或更换硅胶带隧道CVC的小儿(<18岁)IF患者进行了一项经机构审查委员会批准的回顾性研究。评估了患者的人口统计学特征、操作科室(外科与介入放射科)、操作类型(新置管与换管)、血管以及与CVC相关的并发症。并发症包括导管移位、感染、断裂、堵塞/功能障碍及其他。2012年1月开始对IF患者的硅胶CVC采用乙醇封管方案。
确定了29例带隧道CVC的IF患者,共182根导管,累计使用18534导管日。导管置入时的中位年龄为17.1个月(四分位间距[IQR]7.6 - 31.5),每位患者的导管中位数量为5根(IQR 2 - 8)。每1000导管日有19.2例并发症。堵塞/功能障碍是最常见的并发症(每1000导管日6.0例),其次是断裂(每1000导管日5.6例)。导管的中位使用寿命为51.5天(IQR 21 - 129)。经回归分析,校正年龄、置入科室和操作类型后,导管使用寿命较短与年龄较小(P = 0.04)及由介入放射科置入(P < 0.01)有关。导管移位与新置管相关,相对风险为6.5(95%CI 2.2 - 28.8)。
小儿IF患者的CVC并发症频发且导管使用寿命短。CVC移位是一种意外常见的并发症,新置管时会导致通路丧失。可能存在可改进的措施来减轻CVC并发症。